This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Björn Linke - Innovator in Cancer Research
Introduction: Björn Linke is a notable inventor based in Jena, Germany. He is currently associated with the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where he contributes to significant advancements in cancer research. Although he has not yet been granted any patents, his work is focused on innovative therapeutic approaches.
Latest Patent Applications: Björn Linke's latest patent application is titled "Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy." This invention relates to a method for identifying a compound that modulates the interaction of an annexin core domain with a receptor selected from the group of C-type lectin receptors and LRP-1 in a cell. The application highlights potential uses in autoimmune and cancer therapy.
Conclusion: Björn Linke's contributions to cancer research through his innovative patent applications demonstrate his commitment to advancing medical science. His work has the potential to impact therapeutic strategies significantly.